Product image of Minirin (Desmopressin Acetate) supplied by GNH India

Minirin

Active Ingredient:
Desmopressin Acetate
Origin:
EU

Minirin (Desmopressin Acetate)

Desmopressin acetate, the active ingredient in Minirin, is a vasopressin V2 receptor agonist presented as a 10 µg per spray nasal spray for nasal use. It mimics the antidiuretic hormone effect, helping to concentrate urine and reduce excessive water loss. It is indicated for central diabetes insipidus and primary nocturnal enuresis in appropriate patients.

GNH India supplies Minirin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established quality‑assured distribution channels and regulatory support and compliance with EU standards.

Manufacturer / TM Owner

Ferring Läkemedel Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Desmopressin acetate is used to manage disorders of water balance that involve the vasopressin V2 receptor pathway.

  • Central diabetes insipidus: reduces excessive urine output by increasing renal water reabsorption.
  • Primary nocturnal enuresis (bedwetting): lowers nighttime urine volume, supporting dry nights in children and adolescents.
  • Von Willebrand disease and mild hemophilia A: raises factor VIII and von Willebrand factor levels to aid hemostasis (formulation‑specific).

How It Works

  • Desmopressin acetate is a synthetic analog of vasopressin that selectively binds to V2 receptors on the basolateral membrane of renal collecting‑duct cells. Activation of these G‑protein‑coupled receptors stimulates adenylate cyclase, increasing intracellular cAMP, which promotes insertion of aquaporin‑2 water channels into the apical membrane, thereby enhancing water reabsorption and concentrating urine.

Side Effects

Desmopressin nasal spray may cause a range of adverse reactions, from mild and transient to serious, requiring monitoring.

Common Side Effects

  • Nasal irritation or congestion: mild discomfort at the application site.
  • Headache: occasional mild to moderate pain.
  • Mild hyponatremia: low serum sodium without severe symptoms.
  • Thirst: increased desire for fluids.
  • Nausea: occasional upset stomach.
  • Flushing: transient redness of the skin.

Serious or Rare Side Effects

  • Severe hyponatremia with seizures: marked sodium drop leading to neurological events.
  • Water intoxication: excessive water retention causing edema.
  • Allergic reaction: rash, itching, or swelling.
  • Nasal septum perforation: rare tissue damage with prolonged use.
  • Hyponatremic encephalopathy: confusion or coma due to low sodium.

Precautions & Warnings

Before initiating therapy with Desmopressin acetate, clinicians should assess relevant clinical factors and advise patients on safe use.

  • Serum sodium monitoring: check baseline and periodic levels to avoid hyponatremia.
  • Fluid intake restriction: advise limited excessive water consumption.
  • Renal impairment caution: adjust use in patients with reduced kidney function.
  • Elderly patients: monitor closely for hyponatremia risk.
  • Concomitant antidiuretic agents: avoid combined use unless medically justified.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Desmopressin acetate can interact with several medicines, altering its antidiuretic effect or electrolyte balance.

Major Interactions (Avoid)

  • Other ADH analogs (e.g., vasopressin): additive antidiuretic effect may cause severe hyponatremia.
  • Thiazide diuretics: increase risk of hyponatremia.
  • NSAIDs (high dose): potentiate water retention and hyponatremia.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: may enhance antidiuretic action, requiring sodium monitoring.
  • SSRIs and SNRIs: can contribute to hyponatremia, especially in the elderly.
  • Carbamazepine: may increase risk of low sodium levels.

Frequently Asked Questions

Minirin, containing desmopressin acetate, is prescribed for central diabetes insipidus, a condition where the body cannot concentrate urine, and for primary nocturnal enuresis (bedwetting) in children and adolescents. It may also be used in specific bleeding disorders when administered in appropriate formulations.

Desmopressin acetate is a synthetic analogue of the natural hormone vasopressin. It selectively activates V2 receptors in the renal collecting ducts, triggering a cascade that raises intracellular cAMP and promotes the insertion of aquaporin‑2 water channels, which enhances water reabsorption and reduces urine output.

The dosage of Minirin is individualized by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. The prescriber determines the number of sprays per dose and the frequency, and adjustments are made according to clinical monitoring.

The safety of Minirin in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To request Minirin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Minirin is a selective V2‑receptor agonist, offering a targeted antidiuretic effect with a lower risk of vasoconstriction compared with non‑selective vasopressin analogues. Its nasal spray formulation provides rapid onset and convenient dosing, whereas other options may be oral tablets or injectable forms with different pharmacokinetic profiles.

Minirin nasal spray should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the device protected from moisture and direct sunlight, and avoid freezing. If the product reaches its expiry date or shows physical changes, it should be discarded.

Minirin is administered intranasally. The patient tilts the head slightly forward, inserts the spray tip into one nostril, and delivers the prescribed number of sprays. The dose may be repeated in the other nostril if required. Patients should avoid blowing their nose immediately after administration.

The most serious risks include severe hyponatremia, which can lead to seizures, cerebral edema, or hyponatremic encephalopathy. Water intoxication and rapid drops in serum sodium are also critical concerns, especially when fluid intake is not limited or when interacting drugs exacerbate sodium loss.

Minirin is contraindicated in patients with known hypersensitivity to desmopressin or any component of the formulation, in those with uncontrolled hyponatremia, and in individuals who are unable to restrict fluid intake. Caution is also advised for patients with severe renal impairment or chronic heart failure.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.